デフォルト表紙
市場調査レポート
商品コード
1334147

COVID-19試験の世界市場

COVID-19 Testing

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 1417 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
COVID-19試験の世界市場
出版日: 2023年08月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 1417 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

COVID-19試験の世界市場は2030年までに58億米ドルに達する

変化するポストCOVID-19のビジネス環境において、2022年に242億米ドルと推定されるCOVID-19試験の世界市場は、2030年までに58億米ドルの修正規模に達すると予測され、分析期間2022-2030年にかけて-16.3%のCAGRで成長すると予測されます。本レポートで分析したセグメントの1つであるRT-PCRアッセイキットは、CAGR-17.1%を記録し、分析期間終了時には39億米ドルに達すると予測されます。現在進行中のパンデミック後の回復を考慮し、イムノアッセイ検査用ストリップ/カセット分野の成長は、今後8年間のCAGRを-14.4%に修正しました。

米国市場は59億米ドル、中国はCAGR-30.7%の成長予測

米国のCOVID-19試験市場は、2022年には59億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年のCAGR-30.7%で、2030年までに5,690万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、それぞれ2022年から2030年にかけて-15.2%、-14.6%の成長が予測されています。欧州では、ドイツがCAGR約-13.9%で成長すると予測されています。

調査対象企業の例

  • Adaltis Srl
  • Alfa Scientific Designs, Inc.
  • A*STAR Experimental Therapeutics Centre
  • AITbiotech Pte., Ltd.
  • Altimmune, Inc.
  • ADS Biotec, Inc.
  • Accelerate Diagnostics, Inc.
  • AccuBioTech Co., Ltd.
  • Access Bio, Inc.
  • Abwiz Bio Inc.
  • AB Diagnostic Systems GmbH
  • 1drop, Inc.
  • 3B BlackBio Biotech India Ltd.
  • Abacus Diagnostica Oy
  • Aldatu Biosciences

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と問題点
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • 台湾
  • インドネシア
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16930

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global COVID-19 Testing Market to Reach $5.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for COVID-19 Testing estimated at US$24.2 Billion in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at a CAGR of -16.3% over the analysis period 2022-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is projected to record a -17.1% CAGR and reach US$3.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunoassay Test Strips/cassettes segment is readjusted to a revised -14.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $5.9 Billion, While China is Forecast to Grow at -30.7% CAGR

The COVID-19 Testing market in the U.S. is estimated at US$5.9 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$56.9 Million by the year 2030 trailing a CAGR of -30.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -15.2% and -14.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -13.9% CAGR.

Select Competitors (Total 547 Featured) -

  • Adaltis Srl
  • Alfa Scientific Designs, Inc.
  • A*STAR Experimental Therapeutics Centre
  • AITbiotech Pte., Ltd.
  • Altimmune, Inc.
  • ADS Biotec, Inc.
  • Accelerate Diagnostics, Inc.
  • AccuBioTech Co., Ltd.
  • Access Bio, Inc.
  • Abwiz Bio Inc.
  • AB Diagnostic Systems GmbH
  • 1drop, Inc.
  • 3B BlackBio Biotech India Ltd.
  • Abacus Diagnostica Oy
  • Aldatu Biosciences

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. GLOBAL MARKET OVERVIEW
    • Types of COVID-19 Testing
    • Different Types of Coronavirus Tests
    • Performance Analysis of COVID-19 Tests
    • Rapid Tests Help in Controlling the Virus
    • How Will COVID-19 Testing Change in 2021
    • Massive Testing to Become a Way of Life
    • COVID-19 to Drive Hospital and Diagnostic Lab Revenues in 2021
    • COVID-19 Testing Witnesses Staggering Growth Due to Rising Incidence of Corona Virus
    • Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As of September 1st, 2021
    • Total Number of COVID-19 Tests Worldwide in Select Countries: As of September 1st, 2021
    • Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market
    • Select Approved COVID-19 Molecular Assay Tests
    • Immunoassays to Witness Fastest Growth
    • Increasing Demand for Antibody Tests
    • How Antibody (Serology) Tests Were Approved and Developed
    • Select COVID-19 Immunoassay Kits
    • List of US FDA Approved Antigen Tests
    • Nasopharyngeal/Oropharyngeal Swabs Remain Primary Sample Type
    • Diagnostic Laboratories Constitute the Largest End-use Segment
  • RECENT MARKET ACTIVITY
    • Recent Launches
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS AND ISSUES
    • Rising Incidence of Coronavirus Cases Drive the Need for Testing
    • COVID-19 Most Impacted 18 Countries Worldwide: As on September 1st, 2021
    • Pandemic Gives Rise to Innovative Partnership Models
    • Broader Adoption of Reverse-Transcription Polymerase Chain Reaction-based Diagnostics
    • Increasing Point-of-Care Molecular Testing
    • Accelerated Development and Faster Adoption of New Technologies
    • Expansion of Manufacturing Capacity in Asia and Shift of Supply
    • Positioning for the Future
    • Some Innovative Testing Methods for COVID-19:
  • CRISPR
    • Bioluminescence Testing
    • Lab-on-chip Testing
    • LAMpore Kits
    • Covid-19 NudgeBox Test by DNANudge
    • High Risk of Infection in Geriatric Population Drives COVID-19 Testing Market
    • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • Rapid Test Kits Market for COVID-19 to Exhibit Exponential Growth
    • Select Approved COVID-19 Rapid Tests
    • Point-of-Care Tests Witness Rapid Growth
    • High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19
    • Mass Community Testing Holds the Key for Effective COVID-19 Management
    • The Need for Rapid Mass Testing Pushes for Production of Novel Testing Platforms
    • CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market
    • Innovations and Approvals
    • Portable PoC Test with a Smartphone Reader
    • Saliva Test
    • FDA Approves First Molecular Test for Asymptomatic Patients
    • New Molecular Test N1-STOP-LAMP
    • LumiraDx SARS-CoV-2 Antigen Test
    • Integration of Sophisticated Technology to Drive Market Growth
    • Isothermal Amplification: An Effective Alternative to RT-PCR for COVID-19 Testing
    • In-home Testing for Covid-19
    • FDA Authorizes Home Collection Option for LabCorp's COVID-19 Diagnostic Test
    • A Rapid Genomics Strategy to Trace Coronavirus
    • The pioneering of Rapid Genomics
    • Digital Healthcare Gains Spotlight Amid COVID-19 Pandemic
    • Digital Technologies Gaining Adoption Amid COVID-19
    • List of COVID-19 Contact Tracing Apps
    • Amazon Offers FDA-Approved COVID-19 Test
    • Alliance of BMGF and Life Science Companies Pledge to Improve Access
    • Ensuring the Perfect Mix of COVID-19 Testing
    • Testing Rate & Average Turnaround Time to Results as Key Metrics
    • Growing Significance of Pooled Testing
    • Participation of Public & Private Sector
    • Avoiding Supply Mismatch
    • Recent Launches
    • New Test Detects SARS-CoV-2 in Less Than Five Minutes
    • New COVID-19 Test Provides Faster Results and Eliminates False Negatives
    • New Rapid Lateral Flow Immunoassay Developed
    • University of California Develops Rapid, Accurate Testing for SARS-CoV-2 Antibodies
    • Abbott Plans Shipment of Tens of Millions of At-Home Coronavirus Tests Costing $25 in Early 2021
    • Quidel Gains FDA Approval for Sofia 2 Antigen Test
    • Improving Medicine with Innovation and Technology and Massachusetts Institute of Technology Develop COVID-19 Testing Impact Calculator (U.S.)
    • Nanomix Offers eLab COVID-19 Rapid Antigen Test
    • Abbott Receives FDA Approval for BinaxNow
    • Roche Introduces Elecsys® SARS-CoV-2 Antigen test
    • DnaNudge Offers CovidNudge Test
    • Open-Source Toolkit Helps Developing Countries Meet Demand for COVID-19 Diagnostics
    • 3M Joins Hands with MIT's Sikes Lab to Create Rapid & Affordable COVID-19 Test
    • ZTA Biotech Announces "Breakthrough" Development with Antibody Test
    • Molecular Diagnostics Firm QuantuMDx Group Set to Scale up Production of Rapid PCR COVID-19 Device
    • Mologic Granted CE Mark for Rapid Antigen Test
    • FDA Approves Abbott's COVID-19 Antigen Test
    • AptameXTM
    • COVID-19 Testing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Global Market Prospects and Outlook
    • US and Europe Dominate, Asia-Pacific to Witness Fastest Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for RT-PCR Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for RT-PCR Assay Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunoassay Test Strips/Cassettes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Immunoassay Test Strips/Cassettes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Nasopharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Nasopharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Oropharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Oropharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Nasal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Nasal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Specimen Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Other Specimen Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 21: World COVID-19 Testing Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • Market Analysis
    • US Emerges as a Major Market for COVID-19 Tests
    • New Delta Variant Cases Cause Concern
    • Covid-19 Test Supply Chain Issues in the US
    • Challenges Associated with COVID-19 Testing
    • Impact of Surveillance Testing on COVID-19 Test Supply Chain
    • CDC Funding for Covid-19 Vaccination & Testing-Related Activities
    • Escalating Cases of COVID-19 Lead to Spurt in Diagnostic Test Innovations
    • Uptake of At-Home Tests Remains Modest
    • FDA Approves 2 Rapid, At-Home Coronavirus Tests
    • Select Point Of Care Home Tests in the US
    • Pharmacies Now Offering Over-The-Counter Same-day COVID Tests
    • HHS Introduces Pilot Program for Cartridge-based Covid-19 Molecular Test Kits
    • Oura Develops New Smart Ring to Detect Covid-19 Symptoms at Early Stage (Finland)
    • Issues with Existing Testing Options
    • Issues with At-Home and Point-of-Care Rapid Tests
    • Disparate Costs Continue to Plague US Covid-19 Testing
    • With Spike in COVID-19 Cases Roiling Testing Efforts, NIH Eyes on Rapid Tests to Push Capacity
    • Promising Technologies under RADx Program
    • Rapid COVID Tests: Important Tool for Recovery
    • California University Installs Vending Machines to Dispense COVID-19 Testing Kits to Students
    • FDA Assumes Lukewarm Stance to Home Tests despite COVID-19 Testing Lag in US
    • CMS Prioritizes Covid-19 Testing: Announces New Reimbursement Rules
    • CMS Decreases Price for High-Throughput Technology-Based Covid-19 Testing
    • Ageing Demographics: A Major Driving Factor
    • US Elderly Population: Expected Growth Rates Over the Years 2005-2025
    • NIH Funding
    • US FDA Approved COVID-19 Tests
    • Select US FDA Approved COVID-19 Tests (As of August 31, 2021)
    • TABLE 22: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • CANADA
    • Market Analysis
    • New Cheaper and Faster COVID-19 Rapid Test Kit Obtains Approval
    • Canada Approves First Antigen-Based Rapid COVID-19 Test
    • Government of Ontario Introduces Covid-19 Screening Tests at Toronto Pearson International Airport
    • New Federal Rule in Canada for Air Passengers' COVID-19 Tests
    • TABLE 28: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • JAPAN
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • Market Analysis
    • Japan Moves to Low-Cost PCR Testing
    • Rapid Testing Still Costs a Bomb
    • Medical Clinics Edge
    • TABLE 34: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • CHINA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • China's Qingdao Embarks on Ambitious Mission to Test Entire Population of City for COVID-19 in Five Days
    • TABLE 40: China Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: China 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: China 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • EUROPE
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • Market Analysis
    • COVID-19 Testing Drives Revenue Growth
    • Aging Population: A Prime Growth Driver
    • SELECT CE-IVD APPROVED MOLECULAR ASSAYS FOR COVID-19
    • TABLE 46: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • FRANCE
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: France 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • GERMANY
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • UNITED KINGDOM
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • Pandemic Exposes Deficiencies in the UK Healthcare System
    • UK Opens New Vaccine Centers to Expand Asymptomatic Covid-19 Testing
    • Mandatory COVID-19 Tests for UK-Bound Travellers
    • Mass Testing Program for COVID-19
    • Mass Testing in Schools
    • Mass Testing in Cities and Towns
    • New `Mega Labs` to Speed Up COVID-19 Testing in Early 2021
    • TABLE 72: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: UK 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • SPAIN
    • TABLE 78: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Spain 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Spain 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Spain 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • RUSSIA
    • TABLE 84: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Russia 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Russia 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Russia 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • ASIA-PACIFIC
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 8-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2023 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • AUSTRALIA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Australia 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 106: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Australia 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Australia 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • INDIA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • Market Analysis
    • India Hastens Strides toward COVID-19 Testing & Significantly Exceeds Testing Criteria Set by WTO
    • Increase in Daily Tests for COVID-19 in India
    • Indian Researchers Develop Foremost Paper-based Test to Get Handle over COVID-19
    • Researchers in India Successfully Develop Saliva-based Test for COVID-19
    • Home Kits for COVID-19 Testing in India
    • The Rockefeller Foundation Injects New Grants to Boost Covid-19 Testing & Surveillance in India
    • TABLE 110: India Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: India 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 112: India Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 113: India 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 115: India 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: South Korea 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 119: South Korea 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 121: South Korea 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
    • Authorities Succeed In Successfully Evading the Virus Impact
    • Widespread Roll Out of Testing Laboratories Yields Results
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
    • Market Analysis
  • TAIWAN
    • Largest Outbreak of COVID-19 Infection in Taiwan led to Testing Backlog in the Country
  • INDONESIA
    • Indonesia Provided with 1 Million Antigen-Detecting Rapid Diagnostic Tests (Ag-RDTs)
  • LATIN AMERICA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 129: Latin America 8-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2023 & 2030
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 131: Latin America 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 133: Latin America 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Latin America 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • ARGENTINA
    • TABLE 136: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 137: Argentina 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 139: Argentina 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Argentina 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • BRAZIL
    • TABLE 142: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 143: Brazil 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 145: Brazil 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Brazil 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • MEXICO
    • TABLE 148: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 149: Mexico 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 151: Mexico 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Mexico 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 154: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 155: Rest of Latin America 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • MIDDLE EAST
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 160: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 161: Middle East 8-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2023 & 2030
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 163: Middle East 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Middle East 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 167: Middle East 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • IRAN
    • TABLE 168: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 169: Iran 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Iran 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 173: Iran 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • ISRAEL
    • TABLE 174: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 175: Israel 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Israel 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 179: Israel 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • SAUDI ARABIA
    • TABLE 180: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 181: Saudi Arabia 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • UNITED ARAB EMIRATES
    • New Testing Facilities Open Up in the UAE
    • TABLE 186: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 187: UAE 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: UAE 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 191: UAE 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 192: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 193: Rest of Middle East 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030
  • AFRICA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • Market Analysis
    • WHO Pushes for Rapid Testing to Boost Africa's Response to COVID-19 Pandemic
    • COVID-19 Testing Benefits from Existing TB and HIV Laboratory Systems
    • RDTs Arrive in African Countries
    • TABLE 198: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 199: Africa 8-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2023 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Africa 8-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2023 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 203: Africa 8-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2023 & 2030

IV. COMPETITION